Root, Inc. (NASDAQ:ROOT) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Root, Inc. (NASDAQ:ROOT) just released its full-year report and things are looking bullish. Revenues were better than expected, with US$455m in revenue some 20% ahead of forecasts. The company still lost US$10.24 per share, although the losses were marginally smaller than the analysts expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

View our latest analysis for Root

earnings-and-revenue-growth
NasdaqGS:ROOT Earnings and Revenue Growth February 25th 2024

Taking into account the latest results, the current consensus from Root's eight analysts is for revenues of US$887.8m in 2024. This would reflect a major 95% increase on its revenue over the past 12 months. The loss per share is expected to ameliorate slightly, reducing to US$9.64. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$622.0m and losses of US$10.48 per share in 2024. We can see there's definitely been a change in sentiment in this update, with the analysts administering a sizeable upgrade to this year's revenue estimates, while at the same time reducing their loss estimates.

It will come as no surprise to learn thatthe analysts have increased their price target for Root 6.9% to US$11.63on the back of these upgrades. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Root at US$15.00 per share, while the most bearish prices it at US$10.00. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting Root's growth to accelerate, with the forecast 95% annualised growth to the end of 2024 ranking favourably alongside historical growth of 7.5% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 5.8% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Root to grow faster than the wider industry.

Advertisement

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

With that in mind, we wouldn't be too quick to come to a conclusion on Root. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Root analysts - going out to 2026, and you can see them free on our platform here.

It is also worth noting that we have found 4 warning signs for Root (1 is a bit unpleasant!) that you need to take into consideration.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:ROOT

Root

Provides insurance products and services in the United States.

Flawless balance sheet with acceptable track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5370.8% undervalued
46 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HE
PLY logo
HegelBayeBagel on PlaySide Studios ·

PlaySide Studios: Market Is Sleeping on a Potential 10M+ Unit Breakout Year, FY26 Could Be the Rerate of the Decade

Fair Value:AU$0.8460.7% undervalued
11 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
AN
AnimalDoctorKwon
NOTV logo
AnimalDoctorKwon on Inotiv ·

Inotiv NAMs Test Center

Fair Value:US$1.278.3% undervalued
19 users have followed this narrative
2 users have commented on this narrative
6 users have liked this narrative
TH
CGNT logo
TheValueDetector on Cognyte Software ·

This isn’t speculation — this is confirmation.A Schedule 13G was filed, not a 13D, meaning this is passive institutional capital, not acti

Fair Value:US$95.6792.9% undervalued
36 users have followed this narrative
2 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

CO
Coward_Nutlick
ELTX logo
Coward_Nutlick on Elicio Therapeutics ·

Very Bullish

Fair Value:US$10091.3% undervalued
13 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
HU
Humaninsights
SEZL logo
Humaninsights on Sezzle ·

Sezzle's Profits to Soar with 27% Margin Boost

Fair Value:US$113.1844.6% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.9% undervalued
59 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3638.1% undervalued
47 users have followed this narrative
19 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59633.4% undervalued
1288 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative

Trending Discussion

Advertisement